DANIELLE SAIKALI: Open Payments
NPI 1750873709 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 20 payments from 11 companies in 2025. Trend: 2023 $356 · 2024 $14 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $141 |
| Lilly USA, LLC | 3 | $49 |
| Novo Nordisk Inc | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Olympus America Inc. | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: Kerendia, MOUNJARO, VOQUEZNA, XIFAXAN, JARDIANCE, iTIND System, Cologuard Collection Kit, ZEPBOUND.
Industry payments across NC — which companies pay providers there.
